PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsAngioedema
MeSH D000799 - angioedema
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014581:Urticaria
167 Companies
35 Drugs
$
Success rate
D014652:Vascular diseases
1 Company
1 Drug
$
Success rate
D000799: 
Angioedema
24 Companies
6 Drugs
$
Success rate
D054179:Hereditary angioedemas
14 Companies
5 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaClemastine Clemastine  1992-04-21   
PerrigoClemastine Clemastine  1995-11-22   
GSKClemastine Tavist  1992-08-21   
SandozClemastine Clemastine  1993-10-31   
NovartisClemastine, Acetaminophen, Pseudoephedrine Tavist  1982-01-01   
Genus LifesciencesClemastine Clemastine  1994-06-30   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
33%
3/9
Phase 3
50%
4/8
Approved: 4Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Sandoz
Clemastine
Novartis
Acetaminophen,
Pseudoephedrine,
Clemastine,
Histidine,
Terfenadine,
Sodium chloride,
Ige025
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use